| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Department of Medicine, 2Department of Environmental Medicine and the Lung Biology and Disease Program, University of Rochester, Rochester, New York; and 3Schering Plough Research Institute, Kenilworth, New Jersey
Submitted 20 January 2005 ; accepted in final form 10 April 2005
It has been hypothesized that the destruction of lung tissue observed in smokers with chronic obstructive pulmonary disease and emphysema is mediated by neutrophils recruited to the lungs by smoke exposure. This study investigated the role of the chemokine receptor CXCR2 in mediating neutrophilic inflammation in the lungs of mice acutely exposed to cigarette smoke. Exposure to dilute mainstream cigarette smoke for 1 h, twice per day for 3 days, induced acute inflammation in the lungs of C57BL/6 mice, with increased neutrophils and the neutrophil chemotactic CXC chemokines macrophage inflammatory protein (MIP)-2 and KC. Treatment with SCH-N, an orally active small molecule inhibitor of CXCR2, reduced the influx of neutrophils into the bronchoalveolar lavage (BAL) fluid. Histological changes were seen, with drug treatment reducing perivascular inflammation and the number of tissue neutrophils. 
-Glucuronidase activity was reduced in the BAL fluid of mice treated with SCH-N, indicating that the reduction in neutrophils was associated with a reduction in tissue damaging enzymes. Interestingly, whereas MIP-2 and KC were significantly elevated in the BAL fluid of smoke exposed mice, they were further elevated in mice exposed to smoke and treated with drug. The increase in MIP-2 and KC with drug treatment may be due to the decrease in lung neutrophils that either are not present to bind these chemokines or fail to provide a feedback signal to other cells producing these chemokines. Overall, these results demonstrate that inhibiting CXCR2 reduces neutrophilic inflammation and associated lung tissue damage due to acute cigarette smoke exposure.
neutrophil chemokines; emphysema; chronic obstructive pulmonary disease; macrophage inflammatory protein-2; KC
This article has been cited by other articles:
|
|
 |
|
  T. H. Thatcher, R. P. Benson, R. P. Phipps, and P. J. Sime High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L412 - L421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yao, S.-R. Yang, I. Edirisinghe, S. Rajendrasozhan, S. Caito, D. Adenuga, M. A. O'Reilly, and I. Rahman Disruption of p21 Attenuates Lung Inflammation Induced by Cigarette Smoke, LPS, and fMLP in Mice Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 7 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Edirisinghe, S.-R. Yang, H. Yao, S. Rajendrasozhan, S. Caito, D. Adenuga, C. Wong, A. Rahman, R. P. Phipps, Z.-G. Jin, et al. VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction FASEB J, July 1, 2008; 22(7): 2297 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-R. Yang, S. Valvo, H. Yao, A. Kode, S. Rajendrasozhan, I. Edirisinghe, S. Caito, D. Adenuga, R. Henry, G. Fromm, et al. IKK{alpha} Causes Chromatin Modification on Pro-Inflammatory Genes by Cigarette Smoke in Mouse Lung Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 689 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yao, I. Edirisinghe, S. Rajendrasozhan, S.-R. Yang, S. Caito, D. Adenuga, and I. Rahman Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1174 - L1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Churg, M. Cosio, and J. L. Wright Mechanisms of cigarette smoke-induced COPD: insights from animal models Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L612 - L631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Curtis, C. M. Freeman, and J. C. Hogg The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research Proceedings of the ATS, October 1, 2007; 4(7): 512 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yoshida and R. M. Tuder Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease Physiol Rev, July 1, 2007; 87(3): 1047 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yasuda, K. Kasahara, F. Mizuno, K. Nishi, K. Mikasa, and E. Kita Roxithromycin Favorably Modifies the Initial Phase of Resistance against Infection with Macrolide-Resistant Streptococcus pneumoniae in a Murine Pneumonia Model Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1741 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Frink, B. M. Thobe, Y.-C. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry 17beta-Estradiol inhibits keratinocyte-derived chemokine production following trauma-hemorrhage Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L585 - L591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Bonneau, D. Wyss, S. Ferretti, C. Blaydon, C. S. Stevenson, and A. Trifilieff Effect of adenosine A2A receptor activation in murine models of respiratory disorders Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L1036 - L1043. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
